Zhengye Biotechnology (NASDAQ: ZYBT) director Li Guohan files initial Form 3

Rhea-AI Filing Summary

Zhengye Biotechnology Holding Ltd director Li Guohan filed an initial Form 3 insider ownership report. The filing shows no reported purchases, sales, exercises, gifts, or other transactions, and no derivative positions listed, serving as a baseline disclosure of insider status.

Key Figures

Buy transactions: 0 Sell transactions: 0 Net buy/sell shares: 0 shares +1 more

4 metrics

Buy transactions 0 transactionSummary buyCount

Sell transactions 0 transactionSummary sellCount

Net buy/sell shares 0 shares transactionSummary netBuySellShares

Derivative transactions 0 transactionSummary derivativeTransactionCount

Key Terms

Form 3, reportingPersons, transactionSummary, netBuySellDirection

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": ["

transactionSummary regulatory

""transactionSummary": {"

netBuySellDirection financial

""netBuySellDirection": "neutral""

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Guohan (nmn)

(Last) (First) (Middle)

NO.1 LIANMENG ROAD

(Street)

JILIN CITY JILIN PROVINCE 132101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/24/2026

3. Issuer Name and Ticker or Trading Symbol
Zhengye Biotechnology Holding Ltd [ ZYBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Guohan Li	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the ZYBT Form 3 filed by Li Guohan report?

The Form 3 for ZYBT shows director Li Guohan providing an initial insider ownership disclosure. The summary data lists no purchases, sales, exercises, gifts, or other transactions, establishing a baseline regulatory filing as a company director.

Does the ZYBT Form 3 show any insider buying or selling?

No, the ZYBT Form 3 shows zero buy and zero sell transactions. The transaction summary indicates no purchases, no sales, no exercises, no gifts, and no restructuring entries, so it records status rather than trading activity.

Who is the reporting person on the ZYBT Form 3 filing?

The reporting person is Li Guohan, listed as a director of Zhengye Biotechnology Holding Ltd. The filing identifies this role while providing transaction summary data showing no insider trades or derivative positions in the reported information.

Are any derivative securities reported in the ZYBT Form 3?

No derivative securities are reported in this Form 3. The derivativeSummary section is empty and the transaction summary shows zero derivative transactions and zero exercised shares, indicating no options or similar instruments are listed in this disclosure.

What does a netBuySellDirection of neutral mean for ZYBT’s Form 3?

A netBuySellDirection of neutral means no net insider buying or selling is reported. The summary shows buyShares and sellShares both at zero, so there is no directional trading signal from this particular disclosure for Zhengye Biotechnology Holding Ltd.